newsfilter
← Latest News
GlobeNewswire·

Relmada Therapeutics to Report Third Quarter 2026 Financial Results on Thursday, November 12, 2026

CORAL GABLES, Fla., Nov. 03, 2026 (GLOBE NEWSWIRE) -- Relmada Therapeutics, Inc. (NASDAQ:RLMD, "Relmada" or the "Company")), a clinical-stage biotechnology company advancing innovative therapies for